ROSLINCT
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97913008
- Registration number
- 7771028
- Mark type
- Stylized text
- Filed
- 28 Apr 2023
- Published for opposition
- 14 May 2024
- Registered
- 22 Apr 2025
- Attorney of record
- Benjamin P. Harbuck
Goods and services
- Class 035 — Advertising and business services: Business information, consultancy and management services in the fields of designing, building, testing and validating processes and systems for use in cell therapy and gene therapy services; business consultation services in the nature of technology transfer advice and management in the fields of cell therapy and gene therapy; advertising, marketing and promotional services in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
- Class 040 — Treatment of materials: Contract manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; contract manufacturing in the fields of cell therapy and gene therapy; custom manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; custom manufacturing in the fields of cell therapy and gene therapy; custom fabrication and production of cells for others; manufacturing process consulting in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
- Class 041 — Education and entertainment services: Education and training services, namely, classes, seminars, tutorials, conferences and workshops in the fields of cell therapy and gene therapy; provision of online education, training and teaching services, namely, classes, non-downloadable webinars and tutorials in the fields of cell therapy and gene therapy; arranging, organising and conducting of colloquiums, conferences, congresses, seminars and symposiums in the fields of cell therapy and gene therapy; publication of books, scientific papers and texts in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
- Class 042 — Scientific and technological services: Scientific research, development and testing services in the fields of cell therapy and gene therapy; research and development of new products for others in the fields of cell therapy and gene therapy; pharmaceutical and biopharmaceutical research and development services in the fields of cell therapy and gene therapy; scientific consultancy services in the fields of designing, building, testing and validating processes and systems for use in cell therapy and gene therapy services; design and development of computer hardware and software in the biopharmaceutical, cell therapy and gene therapy fields; development of computer databases in the biopharmaceutical, cell therapy and gene therapy fields; scientific development of custom assays for cell therapy and gene therapy; stem cell research services; information, advisory and consultancy services related to the aforesaid
- Class 044 — Medical, beauty and agricultural services: Medical services relating to the removal, treatment and processing of stem cells; medical services, namely, stem cell therapy services; medical services, namely, gene therapy services; stem cell bank services, namely, stem cell storage; information, advisory and consultancy services related to the aforesaid
Owner
- Roslin Cell Therapies Limited, Edinburgh, GB
- Roslin Cell Therapies Limited, Edinburgh, GB
- Roslin Cell Therapies Limited, Edinburgh, GB
Prosecution history
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jan 2025 — USE AMENDMENT FILED
- 13 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION
- 24 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE